Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MK-8931
MK-8931
Can These 2 Health Care Giants Overcome Big Pharma's Alzheimer's Struggles?
Motley Fool
Mon, 02/17/14 - 03:24 pm
Alzheimer's disease
Merck
AstraZeneca
BACE inhibitors
MK-8931
AZD3293
Will Recent Headlines Take Merck Higher?
Wall St Cheat Sheet
Mon, 12/16/13 - 07:41 am
Merck
MK-8931
Merck moves Alzheimer's drug into big trial after safety review
Yahoo/Reuters
Tue, 12/10/13 - 09:22 am
Merck
Alzheimer's disease
MK-8931
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Motley Fool
Mon, 09/30/13 - 04:29 pm
Alzheimer's disease
LY2886721
Eli Lilly
MK-8931
Merck
bapineuzumab
JNJ
solanezumab
Gammagard
Baxter International
Is There Much Hope For Merck In Alzheimer's Drug Clinical Trials?
Seeking Alpha
Thu, 09/12/13 - 08:02 am
Merck
clinical trials
Alzheimer's disease
MK-8931
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thu, 09/5/13 - 08:50 am
Merck
Alzheimer's disease
Pfizer
Eli Lilly
JNJ
bapineuzumab
solanezumab
BACE inhibitors
MK-8931
Merck maintains lead in BACE inhibitors for Alzheimer's
PM Live
Tue, 07/16/13 - 10:47 am
Merck
Alzheimer's disease
BACE inhibitors
MK-8931
Merck and GE Healthcare announce agreement for use of Flutemetamol
Yahoo/Fly on the Wall
Tue, 12/18/12 - 11:07 am
GE Healthcare
Merck
Flutemetamol
PET scans
MK-8931
Another Big Pharma Goes After Alzheimer's
Motley Fool
Sat, 12/8/12 - 11:29 am
Alzheimer's disease
MK-8931
Merck
New drug studies offer patients hope of treatment to slow Alzheimer's within several years
Yahoo/AP
Mon, 12/3/12 - 10:21 am
Alzheimer's disease
Merck
MK-8931
BACE inhibitors
Eli Lilly
Roche
TauRx
LMTX